Fair Value Calculator Fair Value Calculator
EN DE

Fairfax India Holdings (FIH-U) Fair Value & Analysis

Financial Services · CA · Market cap $2.5B

FI Fairfax India Holdings FIH-U · TO
Price$17.80
Fair Value$36.60
Upside+105.6%
Quality65/100
Watch Fairfax India Holdings for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $27.45 – $45.75 📤 Share as image

Fair value as of: Jul 14, 2026

From 15 valuation models · updated 7 days ago

Fair value updated Jul 14, 2026, revised from $36.00 to $36.60 (+1.7%) since Jun 26, 2026. Share price +4.5% over the past month.

Price vs Fair Value (12 months)

$20.12 $15.75 Fair Value $36.60 Jul 2025 Jul 2026

12‑month range $15.75 – $20.12 · fair‑value band $27.45 – $45.75 · the $17.80 price screens below the $36.60 fair value. As of Jul 14, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Fairfax India Holdings (FIH-U) currently trades at $17.80, while our model-based Fair Value estimate is $36.60, implying the stock looks roughly 105.6% undervalued today. We read business quality at 65/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Fairfax India Holdings generated revenue of $515M at a net margin of 48.8%. It earns a return on equity of 10.6%. Net debt stands at $490M. The stock trades on a trailing P/E of 9.8. Fundamentals as of Jul 14, 2026

Our scenario range runs from $27.45 (bear case) to $45.75 (bull case); at $17.80, the current price sits below that range. The share trades about 12% below its 52-week high and 14% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 90% fair-value upside, at 106%, FIH-U screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $515M
Revenue growth (YoY) +3,317%
Net margin 48.8%
Return on equity 10.6%
Free cash flow −$31.7M FY2025
P/E ratio 9.8
More key figures
Operating margin 104%
EPS (TTM) $1.86
EPS growth (YoY) -92.0%
Net debt $490M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 14, 2026. TTM = trailing twelve months.

About the company

Fairfax India Holdings Corporation, together with its subsidiaries, operates as an investment holding company in India. It invests in public and private equity securities and debt instruments, as well as Indian businesses or other businesses with customers, suppliers, or business. The company was incorporated in 2014 and is headquartered in Toronto, Canada.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Fairfax India Holdings reported revenue of $111M in FY2025 versus $542M in FY2021, a compound −32.7%/yr. Reported net income was $418M in FY2025, compounding −4.1%/yr from FY2021.

Revenue −32.7%/yr
FY21 $542M
FY22 $210M
FY23 $490M
FY24 $59.6M
FY25 $111M
Net income −4.1%/yr
FY21 $495M
FY22 $191M
FY23 $372M
FY24 −$41.2M
FY25 $418M

Is FIH-U fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Fairfax India Holdings Fair Value". https://www.fairvalue-calculator.com/stock/FIH-U

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $0.0420 $0.0800 +90%
The Schiehallion Fund Limited MNTN $2.27 $4.54 +100%
BlackRock, Inc UU2 €923.80 €569.37 -38%
Blackstone Inc BX $123.26 $52.88 -57%
BH Macro Limited BHMU $0.0442 $0.0900 +104%
Investor AB INVEB kr 393.75 kr 1,417 +260%
BioPharma Credit PLC BPCR $0.0095 $0.0200 +111%
Brookfield Corporation BN $44.13 $11.09 -75%
KKR & Co KKR $96.90 $61.30 -37%
Brookfield Asset Management Ltd BAM C$66.82 C$34.17 -49%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Fairfax India Holdings (FIH-U) undervalued?
As of Jul 14, 2026, our model estimates a fair value of $36.60 versus a price of $17.80, about +106% (undervalued). Model-based estimate, not financial advice.
What is the fair value of FIH-U?
Our model-based fair value for Fairfax India Holdings is $36.60 (as of Jul 14, 2026), built from audited fundamentals. The current price is $17.80.
What is the quality score of FIH-U?
Fairfax India Holdings has a Quality Score of 65/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Fairfax India Holdings (FIH-U)?
Fairfax India Holdings reported trailing-twelve-month revenue of about $515M (latest available figure, as of Jul 14, 2026).
What is the net profit margin of FIH-U?
The net profit margin of Fairfax India Holdings is about 48.8%, meaning it keeps roughly 48.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Fairfax India Holdings analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.